Monkeys infected with COVID-19 develop immunity in studies, a positive sign for vaccines
Two studies in monkeys published on Wednesday offer some of the first scientific evidence that surviving COVID-19 may result in immunity from reinfection, a positive sign that vaccines under development may succeed, U.S. researchers said on Wednesday.
[Thomson Reuters Foundation] Rome -Thursday's GAVI vaccine summit aims to help people in the developing world get access to any eventual coronavirus vaccine. What are the obstacles?
Novavax Inc said on Thursday the U.S. Department of Defense (DoD) will give the late-stage biotech company up to $60 million to fund the manufacturing of its experimental COVID-19 vaccine.
The director of the National Institutes of Health said Thursday he's concerned that vaccine "skepticism" could hinder the effort to immunize the country against Covid-19.
ConclusionIt is now time to end prejudice and adopt in this fight against Covid-19 alternative therapeutic techniques and practices that historically have proven effective in corresponding situations.
Biotech company Moderna, which is among the leaders in the race to develop a coronavirus vaccine, on Thursday named a sector veteran its new finance chief, as it gears up to launch commercial operations and potentially oversee explosive growth if it succeeds in releasing a Covid-19 treatment.
The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for poorer countries.Reuters Health Information
Brazil this month will start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford and AstraZeneca Plc, Brazil's health surveillance agency Anvisa and the Federal University of Sao Paulo (Unifesp) said.Reuters Health Information
Publication date: May 2020Source: Membrane Technology, Volume 2020, Issue 5Author(s):
Scientists in Sweden are hoping an alpaca named Tyson can help deliver a knockout blow in the fight to develop a treatment or vaccine against the novel coronavirus that has killed nearly 400,000 people worldwide.
The United Nations is among organizations urging those companies developing coronavirus vaccines to create one that would be free to everyone once it's developed